排序方式: 共有20条查询结果,搜索用时 15 毫秒
1.
PIERLUIGI TABACCHI MARIELLA CHIRICOLO MARINELLA CENCI FRANCESCO BARBONI MARCO MANFRINI GAETANO BACCI PIERO PICCI MARIO CAMPANACCI FEDERICO LICASTRO CLAUDIO FRANCECHI 《Tissue antigens》1982,20(4):251-253
A homogeneous group of 53 Caucasian subjects with high-grade osteosarcoma (OS) was typed for HLA-A and B locus antigens. Although no significant differences in the distribution of these antigens were found in comparison with 425 local controls, a trend towards an increase of HLA-B18 and decrease of HLA-B21 was observed. All the patients underwent amputation plus adjuvant chemotherapy and among the 29 patients with a follow-up longer than one year, 9 out of 10 subjects with HLA-A3 antigens developed metastases within a few months. None of the OS patients had the HLA-A3, B7 haplotype which is present in linkage-disequilibrium in the control population. 相似文献
2.
Immunomodulation by Metals 总被引:1,自引:0,他引:1
ZELIKOFF JUDITH T.; SMIALOWICZ RALPH; BIGAZZI PIERLUIGI E.; GOYER ROBERT A.; LAWRENCE DAVID A.; MAIBACH HOWARD I.; GARDNER DONALD 《Toxicological sciences》1994,22(1):1-7
A symposium entitled Immunomodulation by Metals was held atthe 32nd Annual Meeting of the Society of Toxicology (SOT) inNew Orleans, Louisiana. The symposium was cosponsored by theImmunotoxicology and Metals Specialty Sections of SOT and wasdesigned to describe the types of adverse immunological reactionswhich occur in response to environmental and/or occupationalexposure to metals. Epidemiological evidence and underlyingmechanisms responsible for the observed alterations were alsodiscussed. The following is a summary of each of the individualpresentations. 相似文献
3.
Impact on Prognosis of Periprocedural Myocardial Infarction after Percutaneous Coronary Intervention
4.
SUSAN KEATING THEO
DE WITTE STEFAN SUCIU ROEL WILLEMZE MARCEL HAYAT BORIS LABAR LUIGI RESEGOTTI PIERLUIGI ROSSI FERRINI FRANCESCO CARONIA MURIELLE DARDENNE GABRIEL SOLBU MARIA CONCETTA PETTI MARIA LUCE VEGNA FRANCO MANDELLI ROBERT A. ZITTOUN 《British journal of haematology》1998,102(5):1344-1353
To determine whether patients with a HLA-identical sibling donor have a better outcome than patients without a donor, an analysis on the basis of intention-to-treat principles was performed within the framework of the EORTC-GIMEMA randomized phase III AML 8A trial. Patients in complete remission (CR) received one intensive consolidation course. Patients with a histocompatible sibling donor were then allocated allogeneic bone marrow transplantation (alloBMT), the patients without a donor were randomized between autologous BMT (ABMT) and a second intensive consolidation (IC2). 831 patients <46 years old and alive >8 weeks from diagnosis were included. HLA typing was performed in 672 patients. AlloBMT was performed during CR1 in 180 (61%) out of 295 patients with a donor. Another 38 patients were allografted: five in resistant disease, 14 during relapse and 19 in CR2. ABMT was performed in 130 (34%) out of 377 patients without a donor in CR1, in six (2%) patients during relapse and in 38 (10%) patients during CR2. The disease-free survival (DFS) from CR for patients with a donor was significantly longer than for patients without a donor (46% v 33% at 6 years; P = 0.01, RR 0.78, 95% confidence interval 0.63–0.96). The overall survival from diagnosis for patients with a donor was longer, but not statistically significant, than for patients without a donor (48% v 40% at 6 years; logrank P = 0.24). When patients were stratified according to prognostic risk groups, the same trend in favour of patients with a donor was seen for survival duration and the DFS remained significantly longer for this group of patients. 相似文献
5.
6.
FABRIZIO D’ASCENZO M.D. ERIKA CAVALLERO M.D. GIUSEPPE BIONDI‐ZOCCAI M.D. CLAUDIO MORETTI M.D. Ph.D. PIERLUIGI OMEDÈ M.D. MARIO BOLLATI M.D. DAVIDE CASTAGNO M.D. MARIA GRAZIA MODENA M.D. FIORENZO GAITA M.D. IMAD SHEIBAN M.D. 《Journal of interventional cardiology》2012,25(6):611-621
Aims: Randomized clinical trials (RCTs) are the most reliable evidence, even if they require important resource and logistic efforts. Large, cost‐free and real‐world datasets may be easily accessed yielding to observational studies, but such analyses often lead to problematic results in the absence of careful methods, especially from a statistic point of view. We aimed to appraise the performance of current multivariable approaches in the estimation of causal treatment and effects in studies focusing on drug‐eluting stents (DES). Methods and Results: Pertinent studies published in the literature were searched, selected, abstracted, and appraised for quality and validity features. Six studies with a logistic regression were included, all of them reporting more than 10 events for covariates and different length of follow‐up, with an overall low risk of bias. Most of the 15 studies with a Cox proportional hazard analysis had a different follow‐up, with less than 10 events for covariates, yielding an overall low or moderate risk of bias. Sixteen studies with propensity score were included: the most frequent method for variable selection was logistic regression, with underlying differences in follow‐up and less than 10 events for covariate in most of them. Most frequently, calibration appraisal was not reported in the studies, on the contrary of discrimination appraisal, which was more frequently performed. In seventeen studies with propensity and matching, the latter was most commonly performed with a nearest neighbor‐matching algorithm yet without appraisal in most of the studies of calibration or discrimination. Balance was evaluated in 46% of the studies, being obtained for all variables in 48% of them. Conclusions: Better exploitation and methodological appraisal of multivariable analysis is needed to improve the clinical and research impact and reliability of nonrandomized studies. (J Interven Cardiol 2012;25:611–621) 相似文献
7.
ELENA BACCI MANUELA LATORRE SILVANA CIANCHETTI MARIALAURA BARTOLI FRANCESCO COSTA ANTONELLA DI FRANCO LAURA MALAGRINÒ FEDERICA NOVELLI BARBARA VAGAGGINI FEDERICO L. DENTE PIERLUIGI PAGGIARO 《Respirology (Carlton, Vic.)》2012,17(8):1199-1206
Background and Objective: Symptomatic, steroid‐naïve asthmatic patients may have low sputum eosinophil numbers. The aim of the study was to determine whether low sputum eosinophil numbers persisted over time, during treatment with salmeterol monotherapy. Methods: Forty steroid‐naïve, symptomatic asthmatic patients, with sputum eosinophils <3%, were randomized to receive open‐label salmeterol (50 µg twice a day, n = 30) or fluticasone (125 µg twice a day, n = 10) and were then assessed at 1, 3 and 6 months. All patients underwent spirometry, a methacholine challenge test and sputum induction at each visit. Symptom scores and peak expiratory flow were recorded throughout the study. Patients were permitted to withdraw from the study at any time, if they experienced exacerbations or deterioration of symptoms. Results: The average sputum eosinophil percentage remained normal (≤1.9%) in both groups over the study period. The eosinophil percentages were ≤1.9% in 65 of the 80 samples obtained from salmeterol‐treated patients throughout the study period. Eight patients had an asthma exacerbation or deterioration, during which one developed sputum eosinophilia. Twelve patients, 11 of whom were randomized to salmeterol and one to fluticasone, developed transient sputum eosinophilia at least once during the study. This was not associated with asthma exacerbation (except for one patient). Sputum neutrophil percentage did not change in either group. Conclusions: Low sputum eosinophil numbers persisted over 6 months in a majority of patients with non‐eosinophilic asthma who received salmeterol monotherapy. However, transient sputum eosinophilia occurred in 40% indicating that non‐eosinophilic asthma may not be a stable phenotype. 相似文献
8.
TSUYOSHI TAKAMI HEINZ W. KUNZ THOMAS J. GILL PIERLUIGI E. BIGAZZI 《American journal of reproductive immunology (New York, N.Y. : 1989)》1982,2(1):5-7
ABSTRACT: Previous studies from our laboratory using vasectomized rats of different inbred strains have suggested that MHC-linked genes do not play a major role in the formation of autoantibodies to spermatozoa. In the present paper, we demonstrate that sperm autoantibody production is not influenced by genes in the major histocompatibility complex, using vasectomized congenic rats and various crosses between high and low responder strains. We also show that autoimmune responses to spermatozoa are not influenced by genes on the Y-chromo-some. 相似文献
9.
FABRIZIO D'ASCENZO M.D. FRANCESCO COLOMBO M.D. UMBERTO BARBERO M.D. CLAUDIO MORETTI M.D. PIERLUIGI OMEDÈ M.D. MATTHEW J. REED M.D. GIUSEPPE TARANTINI M.D. GIACOMO FRATI M.D. JAMES J. DI NICOLANTONIO PharmD. GIUSEPPE BIONDI ZOCCAI M.D. FIORENZO GAITA M.D. 《Journal of interventional cardiology》2014,27(3):233-241
10.
G. D'ONOFRIO A. M. SALVATI P. BERTI M. P. CAPPABIANCA G. MARSILI M. QUARANTELLI G. ZINI C. CASINI C. DE PHILIPPIS G. MANGO PIERLUIGI ROSSI FERRINI 《International journal of laboratory hematology》1991,13(1):51-66
Summary In two institutions at Rome and Florence we evaluated the clinical sensitivity of two Coulter STKR systems using the NCCLS standard H20-T for leucocyte differential count in a patient population with high prevalence of haematologic abnormalities. Reference ranges of normal leucocytes were obtained on 278 adult subjects. On a population of 455 patient specimens, 200 specimens (44%) were flagged by the STKR because of a distributional abnormality, and 122 (27%) because of a morphological abnormality. Percentage of subtotal agreements between the STKR and the reference manual differential count was 85.4%, with 67.5% full and 20.9% partial agreements. Eight specimens that showed a morphological abnormality with the reference manual differential count were classified as normal by the STKR, with a false normal rate of 6.6%. Analysis of the STKR performance for morphological abnormalities showed acceptable sensitivity (82.0%) and rather low specificity (71.5%), low predictive value of positive results (51.3), high predictive value of negative results (91.5%) and efficiency of 74.3%. The main problems of the STKR differential count were a high rate of false monocyte count, and the misidentification of eosinophilias and low-concentration abnormal cells. 相似文献